Author:
Wadden Thomas A.,Fujioka Ken,Toubro Soren,Gantz Ira,Erondu Ngozi E.,Chen Menghui,Suryawanshi Shailaja,Carofano Wendy,Johnson-Levonas Amy O.,Shapiro Deborah R.,Kaufman Keith D.,Heymsfield Steven B.,Amatruda John M.
Subject
Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference32 articles.
1. The discovery of taranabant, a selective cannabinoid-1 receptor inverse agonist for the treatment of obesity;Hagmann;Arch Pharm (Weinheim),2008
2. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers;Addy;J Clin Pharmacol,2008
3. A self-regulation program for maintenance of weight loss;Wing;N Engl J Med,2006
4. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial;Svetkey;JAMA,2008
5. Effects of four maintenance programs on the long-term management of obesity;Perri;J Consult Clin Psychol,1988
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献